These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22037741)

  • 1. Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors.
    Zhao H; Han KL; Wang ZY; Chen Y; Li HT; Zeng JL; Shen Z; Yao Y
    Med Sci Monit; 2011 Nov; 17(11):CR626-633. PubMed ID: 22037741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS; Lylloff L; Rønne MS; Møllehave LT; Heidemann M; Thuesen BH; Johannesen J; Schou AJ; Husby S; Wedderkopp N; Mølgaard C; Jørgensen NR
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone remodeling markers in the detection of bone metastases in prostate cancer.
    de la Piedra C; Castro-Errecaborde NA; Traba ML; Méndez-Dávila C; García-Moreno C; Rodriguez de Acuña L; Rodriguez-Molina J
    Clin Chim Acta; 2003 May; 331(1-2):45-53. PubMed ID: 12691863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
    Akimoto S; Akakura K; Shimazaki J
    Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
    Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
    Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of cancer-induced bone diseases by bone metabolic marker].
    Takahashi S
    Clin Calcium; 2006 Apr; 16(4):581- 90. PubMed ID: 16582508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone.
    Koizumi M; Yonese J; Fukui I; Ogata E
    BJU Int; 2001 Mar; 87(4):348-51. PubMed ID: 11251528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy--a randomized trial.
    Rief H; Omlor G; Akbar M; Bruckner T; Rieken S; Förster R; Schlampp I; Welzel T; Bostel T; Roth HJ; Debus J
    BMC Cancer; 2016 Mar; 16():231. PubMed ID: 26983672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference intervals for bone turnover markers in Spanish premenopausal women.
    Guañabens N; Filella X; Monegal A; Gómez-Vaquero C; Bonet M; Buquet D; Casado E; Cerdá D; Erra A; Martinez S; Montalá N; Pitarch C; Kanterewicz E; Sala M; Surís X; Torres F;
    Clin Chem Lab Med; 2016 Feb; 54(2):293-303. PubMed ID: 26088062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M; Li Y; Deng W; Zhang Z; Deng Z; Hu Y; Xia W; Xu L
    PLoS One; 2014; 9(8):e103841. PubMed ID: 25117452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on diagnostic value of P1NP and β-CTX in bone metastasis of patients with breast cancer and the correlation between them.
    Zuo CT; Yin DC; Fan HX; Lin M; Meng Z; Xin GW; Zhang YC; Cheng L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5277-5284. PubMed ID: 31298379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
    Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of bone metastasis in men with prostate cancer by measurement of serum ICTP in combination with alkali phosphatase and prostate-specific antigen.
    Kataoka A; Yuasa T; Kageyama S; Tsuchiya N; Habuchi T; Iwaki H; Narita M; Okada Y; Yoshiki T
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):480-4. PubMed ID: 16909972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in bone mass and bone turnover following tibial shaft fracture.
    Veitch SW; Findlay SC; Hamer AJ; Blumsohn A; Eastell R; Ingle BM
    Osteoporos Int; 2006; 17(3):364-72. PubMed ID: 16362144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous osteonecrosis of the knee: biochemical markers of bone turnover and pathohistology.
    Berger CE; Kröner A; Kristen KH; Minai-Pour M; Leitha T; Engel A
    Osteoarthritis Cartilage; 2005 Aug; 13(8):716-21. PubMed ID: 15922633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of some biochemical bone markers for the detection of bone metastases in prostate cancer.
    Westerhuis LW; Delaere KP
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):89-94. PubMed ID: 9056749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.